10 Podcast Episodes
Studying the Promising Role of Bispecific Antibodies in Multiple Myeloma With Ajai Chari, MD
Studying the Promising Role of Bispecific Antibodies in Multiple Myeloma With Ajai Chari, MD
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting ... Read more
21 Jan 2023
•
8mins
Key Presentations on Multiple Myeloma from ASH 2021 with Dr Ajai Chari
Key Presentations on Multiple Myeloma from ASH 2021 with Dr Ajai Chari
Dr Ajai Chari from the Tisch Cancer Institute Clinical Trials Office in New York discusses recent therapeutic advances i... Read more
10 Mar 2022
•
40mins
Clinical Cases: MRD in Real-World Clinical Practice - Gail J. Roboz, MD; Ajai Chari, MD; Steven Coutre, MD; Prashant Kapoor, MD; Aaron C. Logan, MD, PhD
Clinical Cases: MRD in Real-World Clinical Practice - Gail J. Roboz, MD; Ajai Chari, MD; Steven Coutre, MD; Prashant Kapoor, MD; Aaron C. Logan, MD, PhD
MRD in Hematologic Malignancies: Testing Considerations and Challenges
22 Jan 2020
•
43mins
Multiple Myeloma - Ajai Chari, MD
Multiple Myeloma - Ajai Chari, MD
MRD in Hematologic Malignancies: Testing Considerations and Challenges
22 Jan 2020
•
19mins
Multiple Myeloma - Ajai Chari, MD
Multiple Myeloma - Ajai Chari, MD
MRD in Hematologic Malignancies: Testing Considerations and Challenges
22 Jan 2020
•
19mins
Clinical Cases: MRD in Real-World Clinical Practice - Gail J. Roboz, MD; Ajai Chari, MD; Steven Coutre, MD; Prashant Kapoor, MD; Aaron C. Logan, MD, PhD
Clinical Cases: MRD in Real-World Clinical Practice - Gail J. Roboz, MD; Ajai Chari, MD; Steven Coutre, MD; Prashant Kapoor, MD; Aaron C. Logan, MD, PhD
MRD in Hematologic Malignancies: Testing Considerations and Challenges
22 Jan 2020
•
43mins
Antibodies in Practice: SLAMF-7, CD38, Bispecific? Updates: Should They be Used Upfront? - Ajai Chari, MD
Antibodies in Practice: SLAMF-7, CD38, Bispecific? Updates: Should They be Used Upfront? - Ajai Chari, MD
Multiple Myeloma: Treatment Challenges and Updates
20 Dec 2019
•
22mins
Antibodies in Practice: SLAMF-7, CD38, Bispecific? Updates: Should They be Used Upfront? - Ajai Chari, MD
Antibodies in Practice: SLAMF-7, CD38, Bispecific? Updates: Should They be Used Upfront? - Ajai Chari, MD
Multiple Myeloma: Treatment Challenges and Updates
20 Dec 2019
•
22mins
Ajai Chari, MD: DEBATE: Is MRD the new primary goal for multiple myeloma treatment? - No
Ajai Chari, MD: DEBATE: Is MRD the new primary goal for multiple myeloma treatment? - No
Webcast: Looking for One in a Million: Is MRD the New Primary Goal for Multiple Myeloma Treatment?
31 Oct 2018
•
14mins
Ajai Chari, MD: DEBATE: Is MRD the new primary goal for multiple myeloma treatment? - No
Ajai Chari, MD: DEBATE: Is MRD the new primary goal for multiple myeloma treatment? - No
Webcast: Looking for One in a Million: Is MRD the New Primary Goal for Multiple Myeloma Treatment?
31 Oct 2018
•
14mins